A Phase 1/2 Study of DENSPM (N1, N11-diethylnorspermine) in Patients With Unresectable Hepatocellular Carcinoma. +`A phase I/2 study of DENSPM (N1, N11-diethylnorspermine) in patients with unresectable hepatocellular carcinoma
Phase of Trial: Phase I/II
Latest Information Update: 21 Apr 2015
At a glance
- Drugs Diethylnorspermine (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Oct 2008 Status changed from active, no longer recruiting to discontinued.
- 11 Sep 2007 Status change from recruiting to in progress.
- 22 Aug 2005 New trial record.